Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL

被引：17

作者：

Frick, Mareike ^{[1
,2
,3
]}

Bettstetter, Marcus ^{[4
]}

Bertz, Simone ^{[5
]}

Schwarz-Furlan, Stephan ^{[5
,6
]}

Hartmann, Arndt ^{[5
]}

Richter, Thomas ^{[7
]}

Lenze, Dido ^{[8
]}

Hummel, Michael ^{[8
]}

Dreyling, Martin ^{[9
]}

Lenz, Georg ^{[10
,11
]}

Gaumann, Andreas ^{[6
]}

机构：

[1] Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany

[2] Charite Univ Med Berlin, Berlin Inst Hlth, Berlin, Germany

[3] BIH Biomed Innovat Acad, Berlin Inst Hlth BIH, Berlin, Germany

[4] Mol Pathol Sudbayern, Munich, Germany

[5] Univ Hosp Erlangen, Inst Pathol, Erlangen, Germany

[6] Klinikum Kaufbeuren, Inst Pathol, Kaufbeuren, Germany

[7] Inst Pathol, Rosenheim, Germany

[8] Charite, Dept Pathol, Berlin, Germany

[9] Univ Hosp Munich, Dept Internal Med 3, Munich, Germany

[10] Univ Hosp Munster, Dept Med A, Translat Oncol, Munster, Germany

[11] Cluster Excellence EXC 1003, Cells Mot, Munster, Germany

来源：

LEUKEMIA & LYMPHOMA | 2018年 / 59卷 / 05期

基金：

瑞士国家科学基金会;

关键词：

B-CELL LYMPHOMA; ONCOGENIC MYD88; HIGH PREVALENCE; CLASSIFICATION; SURVIVAL;

D O I：

10.1080/10428194.2017.1370546

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1260 / 1263

页数：4

共 50 条

[21] Morphologic Patterns and the Correlation With MYD88 L265P, CD79B Mutations in Primary Adrenal Diffuse Large B-Cell Lymphoma
Chen, Zihang
Zou, Yan
Liu, Weiping
Guan, Pujun
Tao, Qing
Xiang, Chunxiang
Zhang, Wenyan
Ye, Yunxia
Yan, Jiaqi
Zhao, Sha
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (04) : 444 - 455
[22] Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment Outcomes
Xie, Zucheng
Qin, Yan
Chen, Xinrui
Yang, Sheng
Yang, Jianliang
Gui, Lin
Liu, Peng
He, Xiaohui
Zhou, Shengyu
Zhang, Changgong
Tang, Le
Shi, Yuankai
TARGETED ONCOLOGY, 2024, 19 (03) : 383 - 400
[23] 睾丸弥漫大B细胞淋巴瘤中MyD88及CD79B基因突变及意义
马世荣
刘杨
刘芳
王映梅
王哲
郭双平
临床与实验病理学杂志, 2017, 33 (12) : 1311 - 1315
[24] High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites
W Kraan
H M Horlings
M van Keimpema
E J M Schilder-Tol
M E C M Oud
C Scheepstra
P M Kluin
M J Kersten
M Spaargaren
S T Pals
Blood Cancer Journal, 2013, 3 : e139 - e139
[25] In vivo modeling of diffuse large B cell lymphoma (DLBCL) with the myeloid differentiation primary response gene 88 (MYD88) L265P mutation
Ngo, Vu N.
TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S852 - S854
[26] High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites
Kraan, W.
Horlings, H. M.
van Keimpema, M.
Schilder-Tol, E. J. M.
Oud, M. E. C. M.
Scheepstra, C.
Kluin, P. M.
Kersten, M. J.
Spaargaren, M.
Pals, S. T.
BLOOD CANCER JOURNAL, 2013, 3 : e139 - e139
[27] High Prevalence of Oncogenic MYD88 and CD79B Mutations in Intravascular Large B-Cell Lymphoma: Implication for Therapy with Bruton's Kinase Inhibitors?
Somers, Sebastiaan
Jansen, Patty
Veelken, Hendrik
Vermeer, Maarten
Kraan, Willem
Schrader, Anne-Roos
Posthuma, Ward
Nijland, Marcel
Diepstra, Arjan
Kersten, Marie Jose
Pals, Steven
Cleven, Arjen
Vermaat, Joost
BLOOD, 2017, 130
[28] PRESENCE OF A SERUM PARAPROTEIN IN PATIENTS WITH DFFUSE LARGE B CELL LYMPHOMA (DLBCL) IS ASSOCIATED WITH HIGHER CD79B SURFACE EXPRESSION
Maiolo, E.
Bellesi, S.
Malafronte, R.
Iacovelli, C.
Campana, F.
Schiaffini, G.
Puggioni, P. L.
D'innocenzo, S.
Toscano, A.
Alma, E.
Bellisario, F.
Bakaks, A.
Larocca, L. M.
D'alo, F.
Hohaus, S.
HAEMATOLOGICA, 2024, 109 : 100 - 100
[29] Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants-enriched diffuse large B-cell lymphomas
L'Imperio, Vincenzo
Morello, Gaia
Vegliante, Maria Carmela
Cancila, Valeria
Bertolazzi, Giorgio
Mazzara, Saveria
Belmonte, Beatrice
Mangogna, Alessandro
Balzarini, Piera
Corral, Lilia
Lopez, Gianluca
Di Napoli, Arianna
Facchetti, Fabio
Pagni, Fabio
Tripodo, Claudio
EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 (08) : 1350 - 1361
[30] Synergistic cooperation and crosstalk between MYD88L265P and mutations that dysregulate CD79B and surface IgM
Wang, James Q.
Jeelall, Yogesh S.
Humburg, Peter
Batchelor, Emma L.
Kaya, Sarp M.
Yoo, Hee Min
Goodnow, Christopher C.
Horikawa, Keisuke
JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (09): : 2759 - 2776

← 1 2 3 4 5 →